Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral cholinergic disturbances in Alzheimer's disease.

Chemico-biological interactions - 15 Dec 2005

Rakonczay Zoltán, Horváth Zoltán, Juhász Anna, Kálmán János

Abstract excerpt

The most pronounced neurochemical abnormality in Alzheimer's disease (AD) is cholinergic dysfunction in the central nervous system. Peripheral tissues may also be affected, however, including blood. The present study undertook to determine the activity of acetylcholinesterase (AChE) and its molec...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylcholinesterase
Share to Alleles
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Blood Cells

Share to Butyrylcholinesterase

Share to Genotype

Share to Hungary

Source

Identifiers

PMID: 16243305
DOI: 10.1016/j.cbi.2005.10.034

Genes

BCHE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16243305-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral cholinergic disturbances in Alzheimer's disease.PMID 16243305Read ↗

Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients.Semantic proximity Read ↗

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.Semantic proximity Read ↗

Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease.Semantic proximity Read ↗

Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammationSemantic proximity Read ↗

Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.Semantic proximity Read ↗

Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?Semantic proximity Read ↗

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.Semantic proximity Read ↗

Cholinergic dysfunction in diseases with Lewy bodies.Semantic proximity Read ↗

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.Semantic proximity Read ↗

Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.Semantic proximity Read ↗

Clinical and analytical considerations in the utilization of cholinesterase measurements.Semantic proximity Read ↗

Correlation of plasma butyrylcholinesterase concentration with Acethylcholinesterase H353N polymorphism in the inflammatory response of Chagas disease patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.